ROSTOCK, Germany--(BUSINESS WIRE)--CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and pharmaceutical partners to identify and accelerate treatments for rare diseases, today announced that Dr. Arndt Rolfs, CEO and Founder of CENTOGENE, will present at the BIO International Convention, June 4-7, 2018 in Boston, MA.
Date: Wednesday, June 6, 2018
Time: 1:15 pm ET
Location: The Boston Convention and Exhibition Center, Theater 1
CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with genetic diseases. We achieve this through knowledge created by our worldwide diagnostic testing services incorporating global diversity, the world’s leading proprietary human genetic interpretation database, CentoMD® and solutions for pharmaceutical companies developing life-changing orphan drugs.
As one of the most diversified and largest genetic testing companies worldwide, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients and their families. www.centogene.com; www.centoMD.com